EASTON, Pa., May 13, 2026 /PRNewswire/ — Eightco Holdings Inc. (NASDAQ: ORBS) (“Eightco” or the “Company”) today provided an ...
Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring ...
MarketBeat on MSN
Infleqtion Q1 earnings call highlights
What's Behind D-Wave's Spring Rally, and Will It Continue? Infleqtion (NYSE:INFQ) reported record first-quarter revenue and raised its 2026 sales outlook as management pointed to expanding customer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results